GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development manufacture and marketing of products services and complementary digital solutions used in the diagnosis treatment and monitoring of patients in the United States Canada Europe the Middle East Africa China Taiwan Mongolia Hong Kong and internationally. The company operates through four segments: Imaging Ultrasound Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging computed tomography (CT) scanning magnetic resonance (MR) imaging image-guided therapy and X-ray systems as well as women's health products. The Ultrasound segment provides screening diagnosis treatment and monitoring of certain diseases through radiology and primary care women's health cardiovascular and point of care and handheld ultrasound solutions as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices consumable products services and digital solutions through patient monitoring anesthesia delivery and respiratory care diagnostic cardiology and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents including CT angiography and X-ray MR single-photon emission computed tomography positron emission tomography and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago Illinois.